Cargando…

Growth Response and Differentiation of Bone Marrow-Derived Mesenchymal Stem/Stromal Cells in the Presence of Novel Multiple Myeloma Drug Melflufen

Mesenchymal stem/stromal cells (MSCs) are self-renewing and multipotent progenitors, which constitute the main cellular compartment of the bone marrow stroma. Because MSCs have an important role in the pathogenesis of multiple myeloma, it is essential to know if novel drugs target MSCs. Melflufen is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gebraad, Arjen, Ohlsbom, Roope, Miettinen, Juho J., Emeh, Promise, Pakarinen, Toni-Karri, Manninen, Mikko, Eskelinen, Antti, Kuismanen, Kirsi, Slipicevic, Ana, Lehmann, Fredrik, Nupponen, Nina N., Heckman, Caroline A., Miettinen, Susanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103864/ https://www.ncbi.nlm.nih.gov/pubmed/35563880 http://dx.doi.org/10.3390/cells11091574

Ejemplares similares

PB2071: SENSITIVITY OF MULTIPLE MYELOMA TO MELFLUFEN ASSOCIATES WITH DECREASED P53 ACTIVITY AND ENRICHMENT OF DNA DAMAGE REPAIR PATHWAY GENES
por: Miettinen, Juho, et al.
Publicado: (2023)

Aminopeptidase Expression in Multiple Myeloma Associates with Disease Progression and Sensitivity to Melflufen
por: Miettinen, Juho J., et al.
Publicado: (2021)

The Peptide–Drug Conjugate Melflufen Modulates the Unfolded Protein Response of Multiple Myeloma and Amyloidogenic Plasma Cells and Induces Cell Death
por: Flanagan, Ken, et al.
Publicado: (2022)

Vasculogenic Potency of Bone Marrow- and Adipose Tissue-Derived Mesenchymal Stem/Stromal Cells Results in Differing Vascular Network Phenotypes in a Microfluidic Chip
por: Mykuliak, Anastasiia, et al.
Publicado: (2022)

Melflufen, a peptide‐conjugated alkylator, is an efficient anti‐neo‐plastic drug in breast cancer cell lines
por: Schepsky, Alexander, et al.
Publicado: (2020)

Novel Peptide-drug Conjugate Melflufen Efficiently Eradicates Bortezomib-resistant Multiple Myeloma Cells Including Tumor-initiating Myeloma Progenitor Cells
por: Byrgazov, Konstantin, et al.
Publicado: (2021)

P874: DECIPHERING PLASMA CELL HETEROGENEITY AND TUMOR MICROENVIRONMENT IN LIGHT-CHAIN AMYLOIDOSIS USING SINGLE CELL RNA-SEQUENCING
por: Srivastava, A., et al.
Publicado: (2022)

Heat Shock Protein 27 Is Involved in the Bioactive Glass Induced Osteogenic Response of Human Mesenchymal Stem Cells
por: Hyväri, Laura, et al.
Publicado: (2023)

Melflufen - a peptidase-potentiated alkylating agent in clinical trials
por: Wickström, Malin, et al.
Publicado: (2017)

Evaluation of the effect of donor weight on adipose stromal/stem cell characteristics by using weight-discordant monozygotic twin pairs
por: Juntunen, Miia, et al.
Publicado: (2021)

Functional Outcome of Human Adipose Stem Cell Injections in Rat Anal Sphincter Acute Injury Model
por: Kuismanen, Kirsi, et al.
Publicado: (2018)

Simultaneous induction of vasculature and neuronal network formation on a chip reveals a dynamic interrelationship between cell types
por: Isosaari, Lotta, et al.
Publicado: (2023)

P426: HDAC INHIBITORS RESTORE SENSITIVITY TO VENETOCLAX AND NAVITOCLAX IN AML CELLS RESULTING IN THE IRREVERSIBLE DNA DAMAGE
por: Khabusheva, Elmira, et al.
Publicado: (2023)

Porous poly-l-lactide-co-ɛ-caprolactone scaffold: a novel biomaterial for vaginal tissue engineering
por: Sartoneva, Reetta, et al.
Publicado: (2018)

Angiogenic Potential of Human Adipose-Derived Mesenchymal Stromal Cells in Nanofibrillated Cellulose Hydrogel
por: Koivunotko, Elle, et al.
Publicado: (2022)

Authors’ reply: Perspective: The approval and withdrawal of melphalan flufenamide (melflufen): Implications for the state of the FDA
por: Schjesvold, Fredrik H, et al.
Publicado: (2022)

In vitro and in vivo activity of melflufen (J1)in lymphoma
por: Delforoush, Maryam, et al.
Publicado: (2016)

Preclinical activity of melflufen (J1) in ovarian cancer
por: Carlier, Charlotte, et al.
Publicado: (2016)

The Role of Belantamab Mafodotin, Selinexor, and Melflufen in Multiple Myeloma
por: McCurdy, Arleigh, et al.
Publicado: (2022)

Total hip arthroplasty, combined with a reinforcement ring and posterior column plating for acetabular fractures in elderly patients: good outcome in 34 patients
por: Lont, Tõnis, et al.
Publicado: (2019)

Melflufen: A Peptide–Drug Conjugate for the Treatment of Multiple Myeloma
por: Mateos, María-Victoria, et al.
Publicado: (2020)

The approval and withdrawal of melphalan flufenamide (melflufen): Implications for the state of the FDA.
por: Olivier, Timothée, et al.
Publicado: (2022)

Melflufen and Dexamethasone in Heavily Pretreated Relapsed and Refractory Multiple Myeloma
por: Richardson, Paul G., et al.
Publicado: (2021)

High blood metal ion levels in 19 of 22 patients with metal-on-metal hinge knee replacements: A cause for concern
por: Laitinen, Minna, et al.
Publicado: (2017)

Identification of Protein Biomarker Signatures for Acute Myeloid Leukemia (AML) Using Both Nontargeted and Targeted Approaches
por: Dowling, Paul, et al.
Publicado: (2021)

Psychosocial aspects of temporomandibular disorders and oral health-related quality-of-life
por: Miettinen, Ossi, et al.
Publicado: (2012)

Double Disadvantage in a Nordic Welfare State: A Demographic Analysis of the Single-Parent Employment Gap in Finland, 1987–2018
por: Härkönen, Juho, et al.
Publicado: (2023)

In vitro and in vivo anti-leukemic activity of the peptidase-potentiated alkylator melflufen in acute myeloid leukemia
por: Strese, Sara, et al.
Publicado: (2016)

Novel Approaches Outside the Setting of Immunotherapy for the Treatment of Multiple Myeloma: The Case of Melflufen, Venetoclax, and Selinexor
por: Sgherza, Nicola, et al.
Publicado: (2021)

Proteomic and Metabolomic Analysis of Bone Marrow and Plasma from Patients with Extramedullary Multiple Myeloma Identifies Distinct Protein and Metabolite Signatures
por: Dunphy, Katie, et al.
Publicado: (2023)

Correction to: Long-term follow-up results of medial opening wedge high tibia osteotomy with a pre-countered non-locking steel plate
por: Miettinen, Simo S. A., et al.
Publicado: (2021)

Long-term follow-up results of medial opening wedge high tibia osteotomy with a pre-countered non-locking steel plate
por: Miettinen, Simo S. A., et al.
Publicado: (2021)

Preventing White Adipocyte Browning during Differentiation In Vitro: The Effect of Differentiation Protocols on Metabolic and Mitochondrial Phenotypes
por: Herbers, Elena, et al.
Publicado: (2022)

Association of Temporomandibular Disorder Symptoms with Physical Fitness among Finnish Conscripts
por: Miettinen, Ossi, et al.
Publicado: (2021)

Prognostic significance of esterase gene expression in multiple myeloma
por: Kumari, Romika, et al.
Publicado: (2021)

Survival of 11,390 Continuum cups in primary total hip arthroplasty based on data from the Finnish Arthroplasty Register
por: Hemmilä, Matias, et al.
Publicado: (2019)

Perspectives for Clinical Translation of Adipose Stromal/Stem Cells
por: Patrikoski, Mimmi, et al.
Publicado: (2019)

The aetiology of extreme tall stature in a screened Finnish paediatric population
por: Kärkinen, Juho, et al.
Publicado: (2021)

Structure of POPC Lipid Bilayers in OPLS3e Force Field
por: Kurki, Milla, et al.
Publicado: (2022)

GMP-level adipose stem cells combined with computer-aided manufacturing to reconstruct mandibular ameloblastoma resection defects: Experience with three cases
por: Wolff, Jan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_2vqudm3lmvqasgajhq4mbup22k